Synopsis
Synopsis
0
EU WC
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Eqvalan
2. Ivermectin
3. Ivomec
4. Mectizan
5. Mk 933
6. Mk-933
7. Mk933
8. Stromectol
1. Ivermectin
2. Dihydroavermectin B1a
3. 70288-86-7
4. 22,23-dihydroavermectin B1a
5. 70161-11-4
6. Ivermectin Component B1a
7. 71827-03-7
8. Avermectin H2b1a
9. 5-o-demethyl-22,23-dihydroavermectin A1a
10. Chebi:63941
11. 91y2202ouw
12. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2h,7h-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
13. Mk-933
14. (1r,4s,5's,6r,6'r,8r,10e,12s,13s,14e,16e,20r,21r,24s)-6'-[(2s)-butan-2-yl]-21,24-dihydroxy-12-[(2r,4s,5s,6s)-5-[(2s,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one
15. Ivermectin B1a-d2
16. C48h74o14
17. Unii-91y2202ouw
18. 22,23-dihydroavermectin B(1)a
19. Ncgc00163233-01
20. Ivermectin (ivm)
21. Ivm
22. Einecs 276-046-2
23. Dihydro Avermectin Bla
24. Brn 4643153
25. 22,23-dihydro-5-o-demethylavermectin A1a
26. H2b1a
27. Prestwick3_000156
28. Dsstox_cid_3181
29. Ivermectin (mk-0933)
30. Dsstox_rid_76909
31. Dsstox_gsid_23181
32. Bspbio_000292
33. Schembl312795
34. Bpbio1_000322
35. Chembl263291
36. Dtxsid8023181
37. Chebi:94551
38. Hms2089m09
39. Hms2095o14
40. Hms3712o14
41. Wca82703
42. Tox21_112034
43. Bdbm50409816
44. Mfcd30496678
45. S1351
46. Akos027470116
47. Ivermectin Component B1a [mi]
48. Zinc238808778
49. Zinc252286706
50. Ac-6014
51. Ccg-220156
52. Ncgc00186639-01
53. Ncgc00186639-03
54. As-14167
55. Bi166167
56. Cas-71827-03-7
57. Hy-126937
58. Ab00513813
59. Cs-0108408
60. 22,23-dihydroavermectin B1a; Ivermectin
61. Ab00513813-02
62. Ab00513813-03
63. Ab00513813_04
64. Avermectin A1a, 22,23-dihydro-5-o-demethyl-
65. 288i867
66. Ivermectin, Antibiotic For Culture Media Use Only
67. Q-201262
68. Brd-k24652731-001-02-7
69. Brd-k85554912-001-08-9
70. Q27132923
71. Ivermectin, British Pharmacopoeia (bp) Reference Standard
72. Ivermectin, European Pharmacopoeia (ep) Reference Standard
73. Ivermectin, United States Pharmacopeia (usp) Reference Standard
74. Ivermectin, Pharmaceutical Secondary Standard; Certified Reference Material
75. (2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17
76. Clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-o-(2,6-dideoxy-3-o-methyl-alpha-l-arabino-hexopyranosyl)-3-o-methyl-alpha-l-arabino-hexopyranoside
Molecular Weight | 875.1 g/mol |
---|---|
Molecular Formula | C48H74O14 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 8 |
Exact Mass | 874.50785703 g/mol |
Monoisotopic Mass | 874.50785703 g/mol |
Topological Polar Surface Area | 170 Ų |
Heavy Atom Count | 62 |
Formal Charge | 0 |
Complexity | 1680 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 20 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of rosacea
Antiparasitic Agents
Drugs used to treat or prevent parasitic infections. (See all compounds classified as Antiparasitic Agents.)
Insecticides
Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX22 - Ivermectin
P - Antiparasitic products, insecticides and repellents
P02 - Anthelmintics
P02C - Antinematodal agents
P02CF - Avermectines
P02CF01 - Ivermectin
Certificate Number : CEP 2021-382 - Rev 00
Status : Valid
Issue Date : 2024-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2021-477 - Rev 00
Status : Valid
Issue Date : 2022-04-22
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2008-104 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2020-06-08
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 1998-138 - Rev 05
Status : Valid
Issue Date : 2020-02-28
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-146 - Rev 01
Status : Valid
Issue Date : 2008-11-27
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2004-070 - Rev 01
Status : Valid
Issue Date : 2011-08-02
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2010-123 - Rev 00
Status : Expired
Issue Date : 2011-10-25
Type : Chemical
Substance Number : 1336
Certificate Number : R1-CEP 2001-077 - Rev 01
Status : Valid
Issue Date : 2017-10-16
Type : Chemical
Substance Number : 1336
Certificate Number : R0-CEP 2006-008 - Rev 01
Status : Expired
Issue Date : 2010-06-17
Type : Chemical
Substance Number : 1336
Certificate Number : CEP 1999-176 - Rev 06
Status : Valid
Issue Date : 2025-01-10
Type : Chemical
Substance Number : 1336
Registration Number : 304MF10006
Registrant's Address : Estrada Coronel Nicolau de Mesquita Taipa, Macau S. A. R. China
Initial Date of Registration : 2022-01-11
Latest Date of Registration : 2022-01-11
Registration Number : 221MF10281
Registrant's Address : Estrada Coronel Nicolau de Mesquita Taipa, Macau S. A. R. China
Initial Date of Registration : 2009-12-18
Latest Date of Registration : 2021-10-07
Registration Number : 304MF10048
Registrant's Address : 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province, P. R. China 3180...
Initial Date of Registration : 2022-03-02
Latest Date of Registration : 2022-03-02
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2025-02-21
Registration Number : 20250221-211-J-1776
Manufacturer Name : Zhejiang Hisun Pharmaceutica...
Manufacturer Address : 56 Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province, People's Republi...
NDC Package Code : 73377-144
Start Marketing Date : 2021-08-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 73212-079
Start Marketing Date : 2023-10-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77382-0110
Start Marketing Date : 1998-10-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 77382-0100
Start Marketing Date : 1998-10-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-0619
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-08-23
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 55018-221
Start Marketing Date : 2009-03-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55018-121
Start Marketing Date : 1998-07-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60592-316
Start Marketing Date : 2019-12-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-3195
Start Marketing Date : 2023-08-28
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68171-0001
Start Marketing Date : 2007-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
VMF Number : 5672
Submission : 1999-11-22
Status : Inactive
Type : II
VMF Number : 5906
Submission : 2007-09-20
Status : Inactive
Type : II
VMF Number : 6221
Submission : 2018-01-16
Status : Active
Type : II
VMF Number : 5914
Submission : 2008-01-15
Status : Inactive
Type : II
VMF Number : 5476
Submission : 1993-10-22
Status : Inactive
Type : II
VMF Number : 5774
Submission : 2003-06-10
Status : Active
Type : II
VMF Number : 5720
Submission : 2001-05-11
Status : Active
Type : II
VMF Number : 5576
Submission : 1996-11-20
Status : Inactive
Type : II
VMF Number : 5797
Submission : 2004-03-24
Status : Inactive
Type : II
VMF Number : 5553
Submission : 1995-12-14
Status : Active
Type : II
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Norway
Brand Name : Scatol
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Scatol
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 12item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Sweden
Brand Name : Soolantra
Dosage Form : CREAM
Dosage Strength : 10 MG / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Soolantra
Dosage Form : Cream
Dosage Strength : 10 mg/g
Packaging : Tube of plastic
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Soolantra
Dosage Form : Cream
Dosage Strength : 10mg/g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Medical Valley
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Medical Valley
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 10item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin Orifarm
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ivermectin STADA
Dosage Form : Tablet
Dosage Strength : mg
Packaging : Blisterpakning 4item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ivermectin|Pyrantel
Dosage Form : Flavoured Tablet
Dosage Strength : 68MG; 57MG
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1
Regulatory Info :
Dosage : Flavoured Tablet
Dosage Strength : 68MG; 57MG
Brand Name : Ivermectin|Pyrantel
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 12MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Ivermectin
Dosage Form : Liquid Injection
Dosage Strength : 10MG/ML
Packaging : 1 ML, 10 ML, 30 ML, 50 ML, 100 ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging : 1 ML, 10 ML, 30 ML, 50 ML, 100 ML
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 10MG/ML
Brand Name : Ivermectin
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Egypt
Brand Name : Closaverm
Dosage Form : Injection
Dosage Strength : 5MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Egypt
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 5MG; 125MG
Brand Name : Closaverm
Approval Date :
Application Number :
Registration Country : Egypt
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Sterilized Injection
Dosage Strength : 1%/100ML
Packaging : 50ml/100ml/250ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 50ml/100ml/250ml
Regulatory Info :
Dosage : Sterilized Injection
Dosage Strength : 1%/100ML
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Dispersible Tablet
Dosage Strength : 400MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Dispersible Tablet
Dosage Strength : 400MG; 5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : China
Brand Name : Evermec-110 Plus
Dosage Form : Liquid Injection
Dosage Strength : 1%; 10%
Packaging : 50ML,100ML,250ML,500ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 50ML,100ML,250ML,500ML
Regulatory Info :
Dosage : Liquid Injection
Dosage Strength : 1%; 10%
Brand Name : Evermec-110 Plus
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name : Evermec
Dosage Form : Oral Solution/Suspensi...
Dosage Strength : 0.5%
Packaging : 500ML,1000ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 500ML,1000ML
Regulatory Info :
Dosage : Oral Solution/Suspensi...
Dosage Strength : 0.5%
Brand Name : Evermec
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : India
Brand Name : Vibex Plus
Dosage Form : Tablet
Dosage Strength : 50MG; 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 50MG; 2MG
Brand Name : Vibex Plus
Approval Date :
Application Number :
Registration Country : India
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
50
PharmaCompass offers a list of Ivermectin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ivermectin manufacturer or Ivermectin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ivermectin manufacturer or Ivermectin supplier.
PharmaCompass also assists you with knowing the Ivermectin API Price utilized in the formulation of products. Ivermectin API Price is not always fixed or binding as the Ivermectin Price is obtained through a variety of data sources. The Ivermectin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ivermectin, Stromectol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ivermectin, Stromectol, including repackagers and relabelers. The FDA regulates Ivermectin, Stromectol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ivermectin, Stromectol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ivermectin, Stromectol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ivermectin, Stromectol supplier is an individual or a company that provides Ivermectin, Stromectol active pharmaceutical ingredient (API) or Ivermectin, Stromectol finished formulations upon request. The Ivermectin, Stromectol suppliers may include Ivermectin, Stromectol API manufacturers, exporters, distributors and traders.
click here to find a list of Ivermectin, Stromectol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ivermectin, Stromectol DMF (Drug Master File) is a document detailing the whole manufacturing process of Ivermectin, Stromectol active pharmaceutical ingredient (API) in detail. Different forms of Ivermectin, Stromectol DMFs exist exist since differing nations have different regulations, such as Ivermectin, Stromectol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ivermectin, Stromectol DMF submitted to regulatory agencies in the US is known as a USDMF. Ivermectin, Stromectol USDMF includes data on Ivermectin, Stromectol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ivermectin, Stromectol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ivermectin, Stromectol suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ivermectin, Stromectol Drug Master File in Japan (Ivermectin, Stromectol JDMF) empowers Ivermectin, Stromectol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ivermectin, Stromectol JDMF during the approval evaluation for pharmaceutical products. At the time of Ivermectin, Stromectol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ivermectin, Stromectol suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ivermectin, Stromectol Drug Master File in Korea (Ivermectin, Stromectol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ivermectin, Stromectol. The MFDS reviews the Ivermectin, Stromectol KDMF as part of the drug registration process and uses the information provided in the Ivermectin, Stromectol KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ivermectin, Stromectol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ivermectin, Stromectol API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ivermectin, Stromectol suppliers with KDMF on PharmaCompass.
A Ivermectin, Stromectol CEP of the European Pharmacopoeia monograph is often referred to as a Ivermectin, Stromectol Certificate of Suitability (COS). The purpose of a Ivermectin, Stromectol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ivermectin, Stromectol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ivermectin, Stromectol to their clients by showing that a Ivermectin, Stromectol CEP has been issued for it. The manufacturer submits a Ivermectin, Stromectol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ivermectin, Stromectol CEP holder for the record. Additionally, the data presented in the Ivermectin, Stromectol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ivermectin, Stromectol DMF.
A Ivermectin, Stromectol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ivermectin, Stromectol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ivermectin, Stromectol suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ivermectin, Stromectol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ivermectin, Stromectol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ivermectin, Stromectol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ivermectin, Stromectol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ivermectin, Stromectol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ivermectin, Stromectol suppliers with NDC on PharmaCompass.
Ivermectin, Stromectol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ivermectin, Stromectol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ivermectin, Stromectol GMP manufacturer or Ivermectin, Stromectol GMP API supplier for your needs.
A Ivermectin, Stromectol CoA (Certificate of Analysis) is a formal document that attests to Ivermectin, Stromectol's compliance with Ivermectin, Stromectol specifications and serves as a tool for batch-level quality control.
Ivermectin, Stromectol CoA mostly includes findings from lab analyses of a specific batch. For each Ivermectin, Stromectol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ivermectin, Stromectol may be tested according to a variety of international standards, such as European Pharmacopoeia (Ivermectin, Stromectol EP), Ivermectin, Stromectol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ivermectin, Stromectol USP).